Navigation Links
Kincannon & Reed Promotes Jon Leafstedt to Managing Partner

DES MOINES, Iowa, Sept. 22 /PRNewswire/ -- Kincannon & Reed, a leading global executive search firm focused on the food, agribusiness, and life sciences sectors, today announced the promotion of Jon Leafstedt to Managing Partner.  

In his new role, Leafstedt will focus on expanding the firm's client base in North America and its global marketing strategies.  He will continue to be responsible for senior-level executive searches in all areas of the business with particular emphasis in biotechnology, seed, crop protection products, animal health, and renewable fuels.  

Prior to joining Kincannon & Reed in 2007 as a principal, Leafstedt served in wide-ranging executive roles in global agribusinesses and development-stage technology companies, including serving as president of Chromatin, Inc., a plant biotechnology firm.  

"Jon's broad executive experiences in our target industry sectors and excellent track record as a principal at Kincannon & Reed are tremendous assets to our firm and the many clients we serve," said Greg Duerksen, President of Kincannon & Reed.  "His leadership will be instrumental in the continued development and growth of our firm in North America."  

Leafstedt has been a leader in national and state industry associations, including Animal Health Institute, CropLife America, American Feed Industry Association, and Iowa Biotechnology Association.  He serves on the Board of the Iowa Corn Opportunities Fund, a venture capital fund managed by the Iowa Corn Growers Association.  He earned his MBA from the University of Iowa and a BS degree in Animal Science from South Dakota State University.  

Kincannon & Reed ( is the only retained global executive search firm focused exclusively on the food, agribusiness, and life sciences sectors.  Founded in 1981, the company serves clients throughout the world from its offices in the Americas, Europe, and Asia / Pacific.

Media Contact:  Ellen von Fange, 540-941-8331

SOURCE Kincannon & Reed
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Commends Isobionics for Technology Innovation
2. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
3. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
4. NeoStem to Present at Rodman & Renshaws 12th Annual Healthcare Conference
5. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
6. Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference
7. Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference
8. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9. The Female Health Company to Present at Rodman & Renshaws Annual Global Investment Conference on Wednesday, September 15, 2010
10. IGEN Networks Corp. obtains Blue Sky Statutory Compliance in 38 States with Approval of Standard & Poors
11. Uckele Health & Nutrition Ranks on the 2010 Inc. 5000 List
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):